PharmaRoth Labs, Inc. (ROTH)

[SuperC]

Why this is not nor will be a Day Trading Stock:

1.) THE Competitor:
GENERIC NAME: rosiglitazone
BRAND NAME: Avandia

DRUG CLASS AND MECHANISM: Rosiglitazone is an oral drug that reduces the amount of sugar (glucose) in the blood. It is used for treating patients with type 2 diabetes and is in a class of anti-diabetic drugs called thiazolidinediones. The other member of this class is pioglitazone (Actos). Insulin is a hormone produced by the pancreas that is important for controlling the levels of glucose in the blood. Insulin stimulates the cells of the body to remove glucose from the blood and thereby lowers the level of glucose in the blood. Patients with type 2 diabetes cannot make enough insulin or are resistant to the effects of insulin (insulin resistance). As a result, the cells in their bodies do not remove enough glucose from the blood, and the level of glucose rises. Rosiglitazone often is referred to as an "insulin sensitizer" because it attaches to the insulin receptors on cells throughout the body and causes the cells to become more sensitive (more responsive) to insulin and remove more glucose from the blood. At least some insulin must be produced by the pancreas in order for rosiglitazone to work. Rosiglitazone was approved by the FDA in May 1999.
About: rosiglitazone
On September 23, 2010, the U.S. Food and Drug Administration announced that it would restrict access to rosiglitazone through use of a Risk Evaluation and Mitigation Strategy, or REMS.
Every point is important, but also read Question 7 and 8: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm226976.htm
The above is an OLD article, a lot has changed for Avendia and not for the good good!
Avandia has been battling for market share with Actos, the only other drug in the glitazone class that shares similar concerns with Avandia—namely a risk for fractures, weight gain, fluid retention and heart failure. http://www.lawyersandsettlements.com/articles/avandia-heart-attack/avandia-side-effects-heart-attack-35-14706.html

http://www.prweb.com/releases/type-2-diabetes-treatment/sucanon-clinical-trials/prweb9125017.htm

IMO you should be buying because you believe in the product and know enough about other products and how they have failed.

Do not believe the HYPE in that FROI is somehow going to be trading in the pennies within a short period of time, thus you can sell and move on. This one doesn't work that way, FROI is an investment!
I'm one of the best Day Traders around, short and long term... I know because I know... this is not a trading stock.

Your investing in the Product/Patent
Your investing in Luis Lopez
Your investing in how frugal Mgt is at this time
Your investing what MERCK and other possible partnerships are bringing too the table now and in the future.
Your investing because there isn't anything out there good for the millions with TYPE II Diabetes, Sucanon is the only solution and with no side-effects.
Your investing because you have patience!

This is one of those types of investments that when it GOES whether it's 3mths, 6mts or a year... you'll be sorry you were not a shareholder. This is by no means dead-money.

Continue too understand the BIG Picture!

Be kind when you post and please there's no need to BOLD .

sc